PIPV Capital LLC 13D/13G Filings for Ibere Pharmaceuticals (IBER)

PIPV Capital LLC 13D and 13G filings for Ibere Pharmaceuticals:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-08
4:23 pm
Purchase
2021-12-3113GIbere Pharmaceuticals
IBER
PIPV Capital LLC3,450,000
20.000%
3,450,000increase
(New Position)
Filing